Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-Adhoc: Delivery Hero SE expects its food delivery business to break even during the second half of 2022: https://www.deliveryhero.com/newsroom/downloads/
DGAP-Adhoc: Delivery Hero SE expects its food delivery business to break even during the second half of 2022
DGAP-Adhoc: Delivery Hero SE expects its food delivery business to break even during the second half of 2022
Institutional Property Advisors Closes $80 Million San Bernardino County Apartment Asset Sale: https://mms.businesswire.com/media/20201123006309/en/682345/5/MM_logo_288_300_whitebg.jpg
Institutional Property Advisors Closes $80 Million San Bernardino County Apartment Asset Sale


Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE: MMI), announced the sale of The Benson, a 236-unit multifamily property in Upland, California. The asset sold for

Independent Bank Group, Inc. Announces Date for Q4 2021 Earnings Call: https://mms.businesswire.com/media/20210405005114/en/869069/5/4969461_IFBankGroup_Logo_S_4C.jpg
Independent Bank Group, Inc. Announces Date for Q4 2021 Earnings Call


Independent Bank Group, Inc. (NASDAQ: IBTX), the holding company for Independent Bank, will hold a conference call to discuss fourth quarter 2021 results on Tuesday, January 25, 2022 at 8:30 am

DGAP-News: BP p.l.c.: Transaction in Own Shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23826/BP_logo.svg.png
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
New Clinical Evidence Workflow Solution From Wolters Kluwer Accelerates Research Activity Supporting Evidence-based Practice: https://mms.businesswire.com/media/20210914005743/en/905986/5/5047520_WK_VR_01_Pos.jpg
New Clinical Evidence Workflow Solution From Wolters Kluwer Accelerates Research Activity Supporting Evidence-based Practice


Wolters Kluwer, Health today announced the launch of Ovid® Synthesis, a new suite of applications to power highly effective evidence-based workflows in the healthcare setting that complement Ovid’s

QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important enhancements in the commercialization of its QIAstat-Dx syndromic testing solution – which enables laboratories and

Reply Increases Its Presence in North America by Acquiring Enowa LLC and The Spur Group: https://mms.businesswire.com/media/20200310005095/en/778528/5/bg.jpg
Reply Increases Its Presence in North America by Acquiring Enowa LLC and The Spur Group


REPLY [MTA, STAR: REY] strengthens its presence on the US market with the double acquisition of Enowa LLC (www.enowa.com) - a company specialized in consulting and development of solutions based on

NuStar to Participate in the 2022 UBS Winter Infrastructure & Energy Conference: https://www.johnsoncontrols.com/-/media/jci/be/united-states/our-brands/final/johnson-controls.png?h=175&w=400&la=en&hash=BD13FF9939946B200825EE0159B69A1B5CE2C78E
NuStar to Participate in the 2022 UBS Winter Infrastructure & Energy Conference


NuStar Energy L.P. (NYSE: NS) announced today that members of management will participate in virtual meetings with members of the investment community at the 2022 UBS Winter Infrastructure & Energy

Global Market for IT and Business Services Turns in Record 2021, Even as Pace Slows in Q4, ISG Index™ Finds: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Global Market for IT and Business Services Turns in Record 2021, Even as Pace Slows in Q4, ISG Index™ Finds


The global market for technology and business services grew at its fastest pace ever, soaring to record heights in 2021, even as growth slowed in the fourth quarter, according to the latest

DGAP-News: Reply increases its presence in North America by acquiring Enowa LLC and The Spur Group: https://mms.businesswire.com/media/20200310005095/en/778528/5/bg.jpg
DGAP-News: Reply increases its presence in North America by acquiring Enowa LLC and The Spur Group
DGAP-News: Reply increases its presence in North America by acquiring Enowa LLC and The Spur Group
Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer
Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer


Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced

T-Mobile Acquires Rideshare Advertising Network, Octopus Interactive: https://mms.businesswire.com/media/20191206005014/en/398400/5/30686-44937-TMO_Magenta_12.13.jpg
T-Mobile Acquires Rideshare Advertising Network, Octopus Interactive


T-Mobile (NASDAQ: TMUS) today announced the acquisition of Octopus Interactive, the largest national network of interactive video screens inside Uber and Lyft vehicles. This move marks the next

Upland Software Acquires Objectif Lune: https://mms.businesswire.com/media/20191107006065/en/707094/5/Upland-Blue-cmyk.jpg
Upland Software Acquires Objectif Lune


Upland Software, Inc. (Nasdaq: UPLD) announced that it has acquired Objectif Lune Inc., an enterprise software leader in document composition and business communication automation. With the

Bill.com to Report Second Quarter Fiscal 2022 Financial Results on February 3, 2022: https://mms.businesswire.com/media/20210506006167/en/1095511/5/Bill.com_logo_for_Business_Wire.jpg
Bill.com to Report Second Quarter Fiscal 2022 Financial Results on February 3, 2022


Bill.com (NYSE: BILL), a leading provider of cloud-based software that simplifies, digitizes, and automates back-office financial processes for small and midsized businesses (SMBs), will report

AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.P. Morgan Healthcare Conference
AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.P. Morgan Healthcare Conference


AMN Healthcare Services (NYSE: AMN) is providing preliminary unaudited consolidated revenue results for the fourth quarter of 2021 to facilitate the Company’s participation in the 40th Annual J.P

Guidewire Announces Aspire Systems, Inc. as New Consulting Alliance Partner: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Guidewire Announces Aspire Systems, Inc. as New Consulting Alliance Partner


Guidewire (NYSE: GWRE) announced that Aspire Systems, Inc., a global technology services firm providing digital transformation services, has joined Guidewire PartnerConnect as a Consulting alliance

Guidewire Announces Aspire Systems, Inc. as new Consulting Alliance Partner: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Guidewire Announces Aspire Systems, Inc. as new Consulting Alliance Partner


Guidewire (NYSE: GWRE) announced that Aspire Systems, Inc., a global technology services firm providing digital transformation services, has joined Guidewire PartnerConnect as a Consulting alliance

Clovis Oncology Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021


Clovis Oncology, Inc. (NASDAQ:CLVS) today announced its preliminary, unaudited global product revenues for the fourth quarter and full year ended December 31, 2021. The financial information

Perion Network to Announce Fourth Quarter and Annual 2021 Financial Results on February 9, 2022: https://mms.businesswire.com/media/20191107005494/en/755179/5/Perion_triangles_%28002%29.jpg
Perion Network to Announce Fourth Quarter and Annual 2021 Financial Results on February 9, 2022


Perion Network Ltd. (NASDAQ:PERI) a global advertising technology company that delivers holistic solutions across the three main pillars of digital advertising – ad search, social media and display

Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology: https://mms.businesswire.com/media/20191115005085/en/694467/5/aptorum_hori_HQ.jpg
Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology


Regulatory News:



Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including

Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma: https://mms.businesswire.com/media/20191115005085/en/694467/5/aptorum_hori_HQ.jpg
Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma


Regulatory News:



Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces completion of the Phase I clinical

Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers: https://mms.businesswire.com/media/20191115005085/en/694467/5/aptorum_hori_HQ.jpg
Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers


Regulatory News:



Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces the launch of its oncology and

Agilent Presents Thought Leader Award to Professor Jason Kovacic:
Agilent Presents Thought Leader Award to Professor Jason Kovacic


Agilent Technologies Inc. (NYSE: A) today announced that Professor Jason Kovacic has been selected to receive a prestigious Agilent Thought Leader Award. Professor Kovacic is being recognized for

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial


DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31